Cencora (COR)
NYSE: COR · IEX Real-Time Price · USD
223.60
-0.11 (-0.05%)
At close: Jul 19, 2024, 4:00 PM
223.57
-0.03 (-0.01%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Cencora Revenue

Cencora had revenue of $276.54B in the twelve months ending March 31, 2024, with 11.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $68.41B with 7.81% year-over-year growth. In the fiscal year ending September 30, 2023, Cencora had annual revenue of $262.17B with 9.89% growth.

Revenue (ttm)
$276.54B
Revenue Growth
+11.71%
P/S Ratio
0.16
Revenue / Employee
$6,011,663
Employees
46,000
Market Cap
44.60B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023262.17B23.59B9.89%
Sep 30, 2022238.59B24.60B11.50%
Sep 30, 2021213.99B24.09B12.69%
Sep 30, 2020189.89B10.30B5.74%
Sep 30, 2019179.59B11.65B6.94%
Sep 30, 2018167.94B14.80B9.66%
Sep 30, 2017153.14B6.29B4.29%
Sep 30, 2016146.85B10.89B8.01%
Sep 30, 2015135.96B16.39B13.71%
Sep 30, 2014119.57B31.61B35.94%
Sep 30, 201387.96B9.88B12.65%
Sep 30, 201278.08B-614.85M-0.78%
Sep 30, 201178.70B919.20M1.18%
Sep 30, 201077.78B6.02B8.38%
Sep 30, 200971.76B1.57B2.24%
Sep 30, 200870.19B4.52B6.88%
Sep 30, 200765.67B4.86B7.99%
Sep 30, 200660.81B6.24B11.42%
Sep 30, 200554.58B1.46B2.74%
Sep 30, 200453.12B3.54B7.13%
Sep 30, 200349.58B4.35B9.61%
Sep 30, 200245.23B29.04B179.38%
Sep 30, 200116.19B4.55B39.04%
Sep 30, 200011.65B1.84B18.74%
Sep 30, 19999.81B304.33M3.20%
Sep 30, 19989.50B1.20B14.51%
Sep 30, 19978.30B2.64B46.55%
Sep 30, 19965.66B993.77M21.28%
Sep 30, 19954.67B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 360.94B
Humana 109.24B
Takeda Pharmaceutical 28.16B
Becton, Dickinson and Company 19.72B
IQVIA Holdings 15.07B
Haleon 14.31B
Alcon 9.56B
Edwards Lifesciences 6.14B
Revenue Rankings